Acyclic nucleoside phosphonates: A key class of antiviral drugs

被引:561
作者
De Clercq, E [1 ]
Holy, A
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic
关键词
D O I
10.1038/nrd1877
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Almost 20 years after the broad antiviral activity spectrum of the first acyclic nucleoside phosphonates was described, several of these compounds have become important therapies for DNA virus and retrovirus infections. Here, we review the discovery and development of acyclic nucleoside phosphonates, focusing on cidofovir and its potential in the treatment of various herpes-, papilloma-, polyoma-, adeno- and pox-virus infections, adefovir for the treatment of hepatitis B and tenofovir for the treatment of AIDS and the prevention of HIV infections.
引用
收藏
页码:928 / 940
页数:13
相关论文
共 157 条
  • [101] Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS
    Mazzi, R
    Parisi, SG
    Sarmati, L
    Uccella, I
    Nicastri, E
    Carolo, G
    Gatti, F
    Concia, E
    Andreoni, M
    [J]. AIDS, 2001, 15 (15) : 2061 - 2062
  • [102] Treatment of orf poxvirus lesion with cidofovir cream
    McCabe, D
    Weston, B
    Storch, G
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (11) : 1027 - 1028
  • [103] Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication
    Meerbach, A
    Holy, A
    Wutzler, P
    De Clercq, E
    Neyts, J
    [J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1998, 9 (03) : 275 - 282
  • [104] PHOSPHORYLATION OF 9-(2-PHOSPHONOMETHOXYETHYL)ADENINE AND 9-(S)-(3-HYDROXY-2-PHOSPHONOMETHOXYPROPYL)ADENINE BY AMP(DAMP) KINASE FROM L1210 CELLS
    MERTA, A
    VOTRUBA, I
    JINDRICH, J
    HOLY, A
    CIHLAR, T
    ROSENBERG, I
    OTMAR, M
    HERVE, TY
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 44 (10) : 2067 - 2077
  • [105] Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: Long-term results in 4 children
    Milczuk, HA
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2003, 128 (06) : 788 - 794
  • [106] Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients
    Miller, MD
    Margot, N
    Lu, B
    Zhong, LJ
    Chen, SS
    Cheng, A
    Wulfsohn, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05) : 837 - 846
  • [107] Unexpected drug interactions and adverse events with antiretroviral drugs
    Moyle, G
    Boffito, M
    [J]. LANCET, 2004, 364 (9428) : 8 - 10
  • [108] Murono S, 2001, CANCER RES, V61, P7875
  • [109] Fatal lactic acidosis and acute renal failure after addition of tenofovir to an Antiretroviral regimen containing Didanosine
    Murphy, MD
    O'Hearn, M
    Chou, SW
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (08) : 1082 - 1085
  • [110] Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine
    Murry, JP
    Higgins, J
    Matthews, TB
    Huang, VY
    Van Rompay, KKA
    Pedersen, NC
    North, TW
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (02) : 1120 - 1130